Vikas Sinha, EVP & CFO at Alexion Pharmaceuticals, holds 17.82M shares in AlloVir (Ticker: ALVR), holds 74.44K shares in Verona Pharma (Ticker: VRNA), holds 171.86K shares in Alexion Pharmaceuticals (Ticker: ALXN). Most recently, Vikas Sinha Sold ― shares of AlloVir on Nov 20, 2024 for an estimated value of 1.72K.
What is the percentage of profitable transactions made by Vikas Sinha?
The percentage of profitable transactions made by Vikas Sinha is 89%.
What is the average return per transaction made by Vikas Sinha?
The average return per transaction made by Vikas Sinha is 35.10%.
What stocks does Vikas Sinha hold?
Vikas Sinha holds: ALXN, ALVR, VRNA stocks.
What was Vikas Sinha’s latest transaction?
Vikas Sinha latest transaction was an Informative Sell of $1.72K.
What was Vikas Sinha's most profitable transaction?
Vikas Sinha’s most profitable transaction was an Informative Sell of ALVR stock on October 24, 2022. The return on the trade was 80.70%.
What is Vikas Sinha's role in Alexion Pharmaceuticals?
Vikas Sinha's role in Alexion Pharmaceuticals is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.